VJHemOnc is committed to improving our service to you

MDS 2020 | MDS new therapy options

VJHemOnc is committed to improving our service to you

Stephen Nimer

Stephen Nimer, MD, Sylvester Comprehensive Cancer Center and University of Miami, Miami, FL, discusses the importance of developing targeted and epigenetic therapies that effectively eliminate myelodysplastic syndromes (MDS) clones. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter